ExenatideThis is not quite right, we need to consider outcomes for both Rachel and the baby, based on available studies. While exenatide is a GLP-1 receptor agonist that helps with glucose control, it is not recommended for gestational diabetes. There is insufficient safety data regarding the use of GLP-1 receptor agonists like exenatide during pregnancy, and they are generally avoided due to unknown effects on the developing foetus. We should not be prescribing this drug in pregnancy, especially when safer, more established options are available. Let’s try again! |
Map: Michael Green_GEMD_2 (1116)
|
||
|
Review your pathway |